The FDA has finally approved the first generic of GlaxoSmithKline’s Advair blockbuster respiratory diseases inhaler, after years of delays. Even though Advair’s main patent expired in 2010 and ...
Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is ... daily from a Diskus™ inhaler for a 4-week run ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback